Sat, September 3, 2011
[ Sat, Sep 03rd 2011 ]: Market Wire
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Baird Conference
Fri, September 2, 2011
[ Fri, Sep 02nd 2011 ]: Market Wire
The Ensign Group to Present at the Stifel Nicolaus 2011 Healthcare Conference on September 8th
[ Fri, Sep 02nd 2011 ]: Market Wire
SuperGen, Inc. to Change Name and Stock Ticker Symbol
[ Fri, Sep 02nd 2011 ]: Market Wire
Anacor Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
[ Fri, Sep 02nd 2011 ]: Market Wire
Kindred Healthcare Acquires Home Health Company w .. in Northern California, Arizona, Nevada and Utah
[ Fri, Sep 02nd 2011 ]: Market Wire
Vertex Announces Webcast of its Presentations at Two Investor Conferences
[ Fri, Sep 02nd 2011 ]: Market Wire
MSA Elects Dr. Thomas Muschter to Vice President
[ Fri, Sep 02nd 2011 ]: Market Wire
Senetek Announces Exercise of Put Option With Respect to Relief Canyon Project
[ Fri, Sep 02nd 2011 ]: Market Wire
Hawaii, Arkansas and Oklahoma Lead the Nation for .. Workforce, Reveals Quest Diagnostics Drug Testing
Thu, September 1, 2011
[ Thu, Sep 01st 2011 ]: Market Wire
Brookdale Senior Living Completes Acquisition of .. and Right of First Offer on Chartwell Communities
[ Thu, Sep 01st 2011 ]: Market Wire
Advitech Retains Investor Relations Firm
[ Thu, Sep 01st 2011 ]: Market Wire
Nuvo Research to Present at Upcoming Healthcare Conferences
[ Thu, Sep 01st 2011 ]: Market Wire
Burcon files NASDAQ listing application
[ Thu, Sep 01st 2011 ]: Market Wire
STRYKER firma un acuerdo definitivo para adquirir CONCENTRIC MEDICAL, Inc.
[ Thu, Sep 01st 2011 ]: Market Wire
Help Your Favorite Charity Win $1,000 from Cold-EEZE®!
[ Thu, Sep 01st 2011 ]: Market Wire
Delcath Announces Top-Line Results From Metastati .. ohort in Phase II Trial of Chemosaturation System
Wed, August 31, 2011
[ Wed, Aug 31st 2011 ]: Market Wire
Magellana?s Medical Pharmacy Solutions Receives URAC Health Utilization Management Accreditation
[ Wed, Aug 31st 2011 ]: Market Wire
Alexion to Present at the Stifel Nicolaus Healthcare Conference 2011
[ Wed, Aug 31st 2011 ]: Market Wire
Cipher receives Health Canada approval for extended-release tramadol
[ Wed, Aug 31st 2011 ]: Market Wire
Five Star Quality Care, Inc. to Present at the St .. colaus Healthcare Conference on September 7, 2011
[ Wed, Aug 31st 2011 ]: Market Wire
Salix Pharmaceuticals to Present at Three Investment Conferences in September
[ Wed, Aug 31st 2011 ]: Market Wire
Repligen to Present at Upcoming Investor Conferences
[ Wed, Aug 31st 2011 ]: Market Wire
GTx Announces Panel Discussion at Citia?s 6th Annual Biotech Day
[ Wed, Aug 31st 2011 ]: Market Wire
AVEO Pharmaceuticals, Inc. to Present at Upcoming Investment Conferences
Tue, August 30, 2011
[ Tue, Aug 30th 2011 ]: Market Wire
Adamis Pharmaceuticals Begins Prostate Cancer Trial
[ Tue, Aug 30th 2011 ]: Market Wire
Advaxis Announces 2011 Annual Meeting of Stockholders
[ Tue, Aug 30th 2011 ]: Market Wire
Unigene Successfully Defends its Robust Intellectual Property Portfolio
[ Tue, Aug 30th 2011 ]: Market Wire
Fibrocell Science, Inc. to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
[ Tue, Aug 30th 2011 ]: Market Wire
Invacare Social Media Campaign Recognizes aReal Lifea? Winners
[ Tue, Aug 30th 2011 ]: Market Wire
Progenics and Salix Announce FDA Acceptance of sN .. g for RELISTOR® in Patients with Non-Cancer Pain
[ Tue, Aug 30th 2011 ]: Market Wire
ZIOPHARM Oncology Announces First Patient Dosed i .. Phase I Study of ZIN ATI-001 in Advanced Melanoma
[ Tue, Aug 30th 2011 ]: Market Wire
ICON Selected as a Preferred Provider for Early Phase Clinical Development by Bristol-Myers Squibb
Mon, August 29, 2011
[ Mon, Aug 29th 2011 ]: Market Wire
Cubist Pharmaceuticals to Present at September 2011 Investor Conferences
[ Mon, Aug 29th 2011 ]: Market Wire
ImmunoCellular Appoints Helen Kim to Board of Directors
[ Mon, Aug 29th 2011 ]: Market Wire
Media Statement from Amedisys Chief Medical Offic .. Study aChallenges in Posthospital Care: Nurses As
[ Mon, Aug 29th 2011 ]: Market Wire
Labopharm Obtains Interim Court Order for Plan of Arrangement
[ Mon, Aug 29th 2011 ]: Market Wire
ZOLL LifeVest Prescribed by Physicians at All U.S .. r Rolla Hospitals and All 50 aBest Cardiology and
[ Mon, Aug 29th 2011 ]: Market Wire
Cord Blood America Enters Agreement With BancoVid .. Blood Collection Company in San Juan, Puerto Rico
[ Mon, Aug 29th 2011 ]: Market Wire
QIAGEN Completes Acquisition of Cellestis Limited
Fri, August 26, 2011
[ Fri, Aug 26th 2011 ]: Market Wire
Sonomax Reports Second Quarter 2011 Results
[ Fri, Aug 26th 2011 ]: Market Wire
Medwell Announces Shareholder Approval of Plan of Arrangement
[ Fri, Aug 26th 2011 ]: Market Wire
FDA Approves Dendreon's Atlanta Cancer Immunotherapy Manufacturing Facility
[ Fri, Aug 26th 2011 ]: Market Wire
Award-Winning Actress Blythe Danner and Amgen Lau .. h Act 2 Reduce Fractures(TM) Educational Campaign
[ Fri, Aug 26th 2011 ]: Market Wire
New Study from Humana and Wisconsin Health Inform .. lan Costs Decrease When Health Information Exchan
[ Fri, Aug 26th 2011 ]: Market Wire
Center for Proteomics at the Translational Genomi .. te (TGen) Selected as Waters Center of Innovation
[ Fri, Aug 26th 2011 ]: Market Wire
Winner Medical to Attend Investor Conferences in September
Thu, August 25, 2011
[ Thu, Aug 25th 2011 ]: Market Wire
Results of Emergent BioSolutions Phase 1a Study o .. Anthrax Vaccine Published in the Journal Vaccine
[ Thu, Aug 25th 2011 ]: Market Wire
Cyberonics to Participate in 2011 Baird Healthcare Conference

GTx Announces Panel Discussion at Citia?s 6th Annual Biotech Day

MEMPHIS, Tenn.--([ BUSINESS WIRE ])--GTx, Inc. (NASDAQ: GTXI) announced today that Dr. Mitchell S. Steiner, CEO, is scheduled to participate in a panel discussion on the topic aFinally, Lots of Options for Treating Prostate Cancer a at Citia™s 6th Annual Biotech Day on Wednesday, September 7, 2011, at 11:00 a.m. ET. The conference will be held at the Ritz Carlton hotel in Boston, Massachusetts.

"Finally, Lots of Options for Treating Prostate Cancer"

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.